The Economic Times reports that domestic drug makers may not require GMP certificate from WHO. As popularly known within Pharma fraternity, the COPP (Certificate of Pharmaceutical Products) is issued by DCGI on behalf of WHO after a GMP inspection of a firm which intends to export its products. This could be a way forward by DCGI and CDSCO which intents to bring Indian GMPs or Schedule M at par with other international GMP and Quality regulations.
"For marketing medicines within the country, only schedule M certification under the Drugs and Cosmetics Act (DCA) is required. State regulators have been directed that they no longer need to insist for a WHO-GMP certificate from manufacturers while giving them marketing permissions," the official said. GMP is aimed at diminishing the risks inherent in pharmaceutical production. WHO GMP certificate is given based on certain guidelines laid down by WHO through which the regulator ensures that medicines and other medical
products are consistently produced and controlled to the quality standards required for their best use.
For complete News, click here
Saturday, February 14, 2009
Subscribe to:
Post Comments (Atom)

1 comments:
good one.
Post a Comment